Selective degradation of platelet BTK by PROTAC NX-5948 provides antithrombotic benefits without...
Current antithrombotic therapies are effective in reducing thrombotic events but are limited by their associated risk of bleeding. BTK acts as a key signalling switch that drives platelet activation...
biorxiv.org